Negative-strand RNA viruses: genetic engineering and applications - PubMed (original) (raw)
Review
Negative-strand RNA viruses: genetic engineering and applications
P Palese et al. Proc Natl Acad Sci U S A. 1996.
Abstract
The negative-strand RNA viruses are a broad group of animal viruses that comprise several important human pathogens, including influenza, measles, mumps, rabies, respiratory syncytial, Ebola, and hantaviruses. The development of new strategies to genetically manipulate the genomes of negative-strand RNA viruses has provided us with new tools to study the structure-function relationships of the viral components and their contributions to the pathogenicity of these viruses. It is also now possible to envision rational approaches--based on genetic engineering techniques--to design live attenuated vaccines against some of these viral agents. In addition, the use of different negative-strand RNA viruses as vectors to efficiently express foreign polypeptides has also become feasible, and these novel vectors have potential applications in disease prevention as well as in gene therapy.
Similar articles
- Negative-strand RNA viruses: applications to biotechnology.
García-Sastre A. García-Sastre A. Trends Biotechnol. 1998 May;16(5):230-5. doi: 10.1016/s0167-7799(98)01192-5. Trends Biotechnol. 1998. PMID: 9621463 Review. - Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes.
Neumann G, Kawaoka Y. Neumann G, et al. Adv Virus Res. 1999;53:265-300. doi: 10.1016/s0065-3527(08)60352-8. Adv Virus Res. 1999. PMID: 10582103 Review. No abstract available. - Genetic manipulation of negative-strand RNA virus genomes.
García-Sastre A, Palese P. García-Sastre A, et al. Annu Rev Microbiol. 1993;47:765-90. doi: 10.1146/annurev.mi.47.100193.004001. Annu Rev Microbiol. 1993. PMID: 8257115 Review. - New approaches to the development of virus vaccines for veterinary use.
Yamanouchi K, Barrett T, Kai C. Yamanouchi K, et al. Rev Sci Tech. 1998 Dec;17(3):641-53. doi: 10.20506/rst.17.3.1125. Rev Sci Tech. 1998. PMID: 9850535 Review. - RNA virus quasispecies: significance for viral disease and epidemiology.
Duarte EA, Novella IS, Weaver SC, Domingo E, Wain-Hobson S, Clarke DK, Moya A, Elena SF, de la Torre JC, Holland JJ. Duarte EA, et al. Infect Agents Dis. 1994 Aug;3(4):201-14. Infect Agents Dis. 1994. PMID: 7827789 Review.
Cited by
- Rescue of influenza A virus from recombinant DNA.
Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, García-Sastre A. Fodor E, et al. J Virol. 1999 Nov;73(11):9679-82. doi: 10.1128/JVI.73.11.9679-9682.1999. J Virol. 1999. PMID: 10516084 Free PMC article. - Noncytopathic Sindbis virus RNA vectors for heterologous gene expression.
Agapov EV, Frolov I, Lindenbach BD, Prágai BM, Schlesinger S, Rice CM. Agapov EV, et al. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12989-94. doi: 10.1073/pnas.95.22.12989. Proc Natl Acad Sci U S A. 1998. PMID: 9789028 Free PMC article. - A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
Huang Z, Elankumaran S, Yunus AS, Samal SK. Huang Z, et al. J Virol. 2004 Sep;78(18):10054-63. doi: 10.1128/JVI.78.18.10054-10063.2004. J Virol. 2004. PMID: 15331738 Free PMC article. - Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.
Stope MB, Karger A, Schmidt U, Buchholz UJ. Stope MB, et al. J Virol. 2001 Oct;75(19):9367-77. doi: 10.1128/JVI.75.19.9367-9377.2001. J Virol. 2001. PMID: 11533200 Free PMC article. - Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.
Tompkins SM, Lin Y, Leser GP, Kramer KA, Haas DL, Howerth EW, Xu J, Kennett MJ, Durbin RK, Durbin JE, Tripp R, Lamb RA, He B. Tompkins SM, et al. Virology. 2007 May 25;362(1):139-50. doi: 10.1016/j.virol.2006.12.005. Epub 2007 Jan 23. Virology. 2007. PMID: 17254623 Free PMC article.
References
- J Virol. 1987 Dec;61(12):3809-19 - PubMed
- Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415-9 - PubMed
- Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 - PubMed
- Proc Natl Acad Sci U S A. 1990 May;87(10):3802-5 - PubMed
- J Virol. 1991 May;65(5):2711-3 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical